This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of various biologically active molecules. Its structure, featuring a piperazine ring and a chloropyrazin-2-yl moiety, makes it valuable for designing compounds targeting central nervous system disorders, particularly those involving dopamine and serotonin receptors. It is often employed in the creation of potential therapeutic agents for conditions like schizophrenia, depression, and anxiety. Additionally, its reactive sites allow for further functionalization, enabling the development of diverse chemical libraries for drug discovery and optimization.